Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22
EUROPEAN JOURNAL OF HUMAN GENETICS
Authors: Golla, A; Jansson, A; Ramser, J; Hellebrand, H; Zahn, R; Meitinger, T; Belohradsky, BH; Meindl, A
Abstract
Chronic recurrent multifocal osteomyelitis (CRMO) is characterised by recurrent inflammatory lesions in the metaphyses of long bones and usually affects children and adolescents. Similarity with an autosomal recessive mouse disorder (cmo, chronic multifocal osteomyelitis) prompted us to perform a family based association study with two markers on chromosome 18q in the region homologous to the cmo localisation of the mouse. We found a significant association of CRMO with a rare allele of marker D18S60, resulting in a haplotype relative risk (HRR) of 18. This suggests the existence of a gene in this region contributing in a significant manner to the aetiology of CRMO and concomitantly demonstrates evidence for a genetic basis of CRMO for the first time. This gene is different from RANK, which is mutated in familial expansile osteolysis (FEO), but not in CRMO. Mutation screening in RANK and the genes PIGN and KIAA1468 led to detection of two variants (one in RANK and one in PIGN), which are in linkage disequilibrium with the rare D18S60 allele, but not independently associated with CRMO.
Involvement of TNFRSF11A Molecular Defects in Autoinflammatory Disorders
ARTHRITIS & RHEUMATOLOGY
Authors: Jeru, Isabelle; Cochet, Emmanuelle; Duquesnoy, Philippe; Hentgen, Veronique; Copin, Bruno; Mitjavila-Garcia, Maria Teresa; Sheykholeslami, Shayan; Le Borgne, Gaelle; Dastot-Le Moal, Florence; Malan, Valcric; Karabina, Sonia; Mahevas, Mathieu; Chantot-Bastaraud, Sandra; Lecron, Jean-Claude; Faivre, Laurence; Amselem, Serge
Abstract
Objective. Autoinflammatory disorders are caused by a primary dysfunction of the innate immune system. Among these disorders are hereditary recurrent fevers, which are characterized by recurrent episodes of fever and inflammatory manifestations affecting multiple tissues. Hereditary recurrent fevers often lack objective diagnostic criteria, thereby hampering the identification of disease-causing genes. This study was undertaken to identify a gene responsible for hereditary recurrent fevers. Methods. Copy number variations and point mutations were sought by array-comparative genomic hybridization and polymerase chain reaction sequencing, respectively. Serum cytokine levels were measured using Luminex technology. The effect of TNFRSF11A molecular defects on NF-kappa B signaling in cells expressing wild-type and mutated forms of the receptor was evaluated by luciferase assay. Results. A patient with multiple congenital anomalies and hereditary recurrent fever was found to carry a de novo heterozygous complex chromosomal rearrangement encompassing a duplication of TNFRSF11A, a gene known to regulate fever in rodents. We also identified a heterozygous frameshift mutation (p. Met416Cysfs*110) in TNFRSF11A in a mother and daughter with isolated hereditary recurrent fever. This mutation was associated with increased secretion of several inflammatory cytokines (tumor necrosis factor alpha [TNF alpha], interleukin-18 [IL-18], IL-1 receptor antagonist, interferon-gamma) and altered the biologic effects of the receptor on NF-kappa B signaling. The disease in the patients described herein exhibits striking clinical similarities to TNF receptor-associated periodic syndrome, another hereditary recurrent fever involving a gene of the same family (TNFRSF1A). Conclusion. The involvement of TNFRSF11A in hereditary recurrent fever highlights the key role of this receptor in innate immunity. The present results also suggest that TNFRSF11A screening could serve as a new diagnostic test for autoinflammatory disorders.